Ibudol (Ibuprofen)

Ibuprofen in Ibudol works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in peripheral tissues. This inhibition lowers prostaglandin production, which diminishes pain signalling, reduces inflammation, and helps lower fever at the site where the product is applied.

The appropriate amount of Ibudol to apply is determined by the prescribing healthcare professional based on the specific indication, patient age, and skin area involved. Patients should follow the prescriber’s instructions and the product label for the correct quantity and frequency of application.

The safety of topical ibuprofen during pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Ibudol with their healthcare provider to weigh potential risks and benefits.

To request Ibudol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and necessary import documentation.

Ibudol delivers ibuprofen directly to the skin, providing localized relief with lower systemic exposure compared with oral ibuprofen. This can reduce the risk of gastrointestinal and renal side effects, but the depth of analgesia may be limited to superficial tissues, whereas oral tablets affect the whole body.

Store Ibudol at room temperature, ideally below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat and direct sunlight. Do not freeze the container, and ensure the cap is tightly closed to maintain product stability.

Ibudol is applied topically to clean, dry skin. The prescribed amount is spread thinly over the affected area and gently massaged until absorbed. Hands should be washed after application, and the product should not be covered with occlusive dressings unless directed by a healthcare professional.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and systemic NSAID toxicity leading to renal impairment or gastrointestinal bleeding if significant absorption occurs. Patients should seek immediate medical attention if they notice widespread rash, blistering, or signs of an allergic reaction.

Ibudol should be avoided by individuals with known hypersensitivity to ibuprofen or any NSAID, those with active skin infections or open wounds at the intended site of application, and patients with a history of severe allergic skin reactions. Consultation with a healthcare professional is essential before use in these cases.